The United States Handheld Ultrasound Market size was estimated at USD 397.29 million in 2025 and is projected to reach approximately USD 1.27 billion by 2035, growing at a CAGR of 12.3% from 2026 to 2035. Handheld ultrasound is becoming a strategic point-of-care imaging asset, enabling clinicians to obtain immediate diagnostic information, reduce dependence on centralized imaging infrastructure, and extend ultrasound access across hospital and community-based care.
Key Highlights
- The 3D/4D imaging segment accounted for approximately 46.4% of technology revenue in 2025, reflecting demand for enhanced visualization and advanced imaging capabilities.
- Hospitals represented approximately 42.1% of end-user revenue in 2025, supported by emergency, critical care, and bedside diagnostic requirements.
- AI-assisted image acquisition, automated measurements, and clinical decision-support features are becoming important product differentiation factors.
- Demand for decentralized diagnostics and faster bedside assessments is strengthening procurement across emergency departments, primary care, and specialty clinics.
- Commercial advantage is shifting toward vendors combining image quality, multi-specialty probe capability, software integration, training, and predictable lifecycle costs.
United States Handheld Ultrasound Market Overview
The handheld ultrasound industry occupies a distinct position within medical imaging by combining diagnostic ultrasound functionality with compact, mobile hardware and software-led workflows. Unlike conventional cart-based systems, handheld devices are designed for bedside assessments, mobile clinical teams, outpatient consultations, emergency response, and locations where access to full-scale imaging equipment remains constrained. Their commercial value is measured through workflow acceleration, portability, equipment utilization, and the ability to bring imaging closer to the point of clinical decision-making.
Procurement decisions increasingly extend beyond the initial probe purchase. Hospitals and healthcare networks assess image quality, transducer versatility, device durability, software licensing, cybersecurity, connectivity, data storage, and compatibility with electronic health records and picture archiving and communication systems. Smartphone-connected devices offer lower equipment footprints, while integrated-display configurations appeal to buyers seeking dedicated imaging hardware and reduced dependence on personal mobile devices.
Deployment maturity differs across clinical specialties. Emergency medicine, critical care, cardiology, and musculoskeletal applications have established practical use cases, while primary care, remote medicine, and home-based services are expanding the addressable environment. Institutional adoption also depends on credentialing, operator training, image documentation, quality assurance, and clinical governance. Vendors that address these operational requirements alongside device performance are better positioned to secure enterprise-wide purchasing agreements and recurring software revenue.
Key Market Drivers & Industrial Demand Dynamics
The growing use of point-of-care ultrasound is a primary commercial driver. Healthcare providers face pressure to shorten diagnostic pathways, improve patient throughput, and reduce delays associated with transporting patients to centralized imaging departments. Handheld systems allow trained clinicians to conduct focused examinations during initial assessments, bedside rounds, emergency triage, and outpatient consultations. This capability is particularly relevant when immediate visualization supports decisions involving cardiac function, fluid status, abdominal conditions, vascular access, or pulmonary findings. Hospitals evaluate the technology through its contribution to workflow efficiency and clinical accessibility rather than treating it solely as a smaller alternative to conventional ultrasound. As procurement shifts toward distributed imaging resources, vendors with reliable image quality, straightforward operation, and integration into clinical documentation workflows gain stronger institutional relevance.
The burden of cardiovascular, respiratory, abdominal, and musculoskeletal conditions strengthens demand across multiple care environments. These conditions generate recurring diagnostic requirements in emergency departments, intensive care units, specialty practices, and community clinics. Handheld ultrasound supports focused examinations that complement physical assessment and established diagnostic pathways. Cardiology and critical care teams value rapid bedside cardiac and lung assessment, while musculoskeletal specialists use compact systems for tendon, joint, and soft-tissue evaluation. Primary care providers also benefit from access to focused imaging without maintaining a conventional ultrasound suite. Commercial demand therefore extends across both high-acuity institutions and distributed outpatient networks. Manufacturers that offer specialty-specific presets, multiple transducer options, and training resources can address a broader range of clinical purchasing requirements.
Advances in semiconductor-based transducers, miniaturized electronics, battery performance, and image-processing software are improving the practical capabilities of handheld devices. Single-probe platforms simplify equipment management by supporting multiple examination types through one compact scanner, while dual-probe configurations provide different acoustic characteristics for specialized assessments. Improvements in beamforming, signal processing, Doppler functionality, and image enhancement strengthen the clinical utility of compact systems. These developments influence procurement because buyers increasingly compare handheld devices against the performance requirements of larger systems rather than evaluating portability alone. Vendors with differentiated transducer architecture and dependable imaging performance gain opportunities in departments that require repeatable examinations and multi-specialty use.
Software and artificial intelligence are expanding the commercial value proposition. Automated measurements, image optimization, anatomy recognition, examination guidance, and structured reporting reduce repetitive tasks and support less experienced operators. These capabilities are relevant to clinical teams seeking consistent workflows across multiple locations and practitioners. AI functions also create opportunities for software subscriptions, application-specific upgrades, and differentiated service packages. However, adoption depends on regulatory clearance, clinical validation, transparent performance limitations, and appropriate human oversight. Vendors that integrate software into a secure and interoperable device ecosystem can strengthen customer retention and generate revenue beyond the initial hardware transaction.
Expansion of outpatient care, rural healthcare access, emergency medical services, and mobile clinical programs creates additional demand. Smaller facilities often face capital constraints, limited imaging infrastructure, and difficulty maintaining dedicated ultrasound departments. Handheld devices offer a compact alternative for focused diagnostic applications, provided that clinicians receive suitable training and that referral pathways remain available for comprehensive examinations. Procurement decisions in these settings emphasize affordability, durability, battery life, connectivity, and ease of maintenance. Public health programs and healthcare networks also assess the potential to standardize devices across geographically distributed teams. This demand structure supports vendors that provide scalable purchasing arrangements, education, technical support, and flexible software access.
- ■ By Device Configuration
- ■ SmartphoneConnected Handheld Systems
- ■ TabletConnected Handheld Systems
- ■ Handheld Systems with Integrated Display
- ■ By Imaging Technology
| Year | 1st QTR | 2nd QTR | 3rd QTR | 4th QTR |
|---|---|---|---|---|
| 2025 | XX Mn/Bn | XX Mn/Bn | XX Mn/Bn | XX Mn/Bn |
| 2024 | XX Mn/Bn | XX Mn/Bn | XX Mn/Bn | XX Mn/Bn |
| 2023 | XX Mn/Bn | XX Mn/Bn | XX Mn/Bn | XX Mn/Bn |
| 2026 | XX Mn/Bn | 2031 | XX Mn/Bn |
| 2027 | XX Mn/Bn | 2032 | XX Mn/Bn |
| 2028 | XX Mn/Bn | 2033 | XX Mn/Bn |
| 2029 | XX Mn/Bn | 2034 | XX Mn/Bn |
| 2030 | XX Mn/Bn | 2035 | XX Mn/Bn |
Segmentation Analysis
United States Handheld Ultrasound Market, By Device Configuration
Device configuration distinguishes how the scanning hardware and viewing interface are packaged for clinical use. Smartphone-connected systems pair a compact probe with a compatible mobile device, reducing dedicated hardware requirements and supporting flexible deployment across departments. Tablet-connected configurations provide a larger viewing surface for image interpretation, teaching, and collaborative examinations. Handheld systems with integrated displays combine scanning and visualization in a dedicated unit, appealing to facilities that prioritize standardized equipment, controlled device access, and simplified clinical workflows. Buyers compare portability, screen size, battery management, durability, and total acquisition cost. Smartphone-connected systems hold a strong commercial position because they reduce equipment footprint and support mobile workflows, while integrated-display configurations attract buyers seeking dedicated clinical devices. Tablet-connected systems serve workflows where larger image presentation improves usability. Growth is strongest in compact wireless configurations that combine portability with enterprise-grade security and image management.
United States Handheld Ultrasound Market, By Imaging Technology
Imaging technology determines the diagnostic information available to clinicians and influences the range of supported examinations. 2D imaging remains foundational for anatomical visualization and focused bedside assessments, making it a core purchasing requirement across general clinical environments. 3D/4D imaging provides volumetric visualization and supports selected applications requiring spatial assessment. Doppler imaging evaluates blood flow and supports cardiac, vascular, and related examinations. Buyers assess image resolution, penetration, frame rate, measurement functions, and specialty-specific presets. 2D imaging maintains broad utilization because it supports routine scanning and focused diagnostic workflows. Doppler imaging carries strong commercial relevance in cardiovascular and vascular applications, while 3D/4D functionality represents an advanced capability segment as processing performance and compact transducer technology improve. Vendors compete through the balance of imaging modes, clinical usability, and software-assisted interpretation rather than the number of modes alone.
United States Handheld Ultrasound Market, By Transducer Type
Transducer type defines the acoustic design and anatomical access supported by a handheld system. Linear array probes serve superficial structures, vascular access, and musculoskeletal examinations. Phased array probes support cardiac imaging and examinations requiring a small footprint between ribs. Curvilinear array probes support abdominal and deeper tissue assessments. Endocavity probes address selected internal examinations, while multi-array configurations combine more than one transducer arrangement within a single device or probe architecture. Procurement teams select configurations according to specialty coverage, examination frequency, and the need to minimize the number of devices. Linear and phased array options maintain broad institutional relevance because they support common vascular, musculoskeletal, and cardiac workflows. Multi-array systems are gaining commercial traction by reducing equipment duplication and supporting broader use across departments. Curvilinear probes remain important for abdominal and obstetric applications, while endocavity configurations serve narrower specialist requirements.
United States Handheld Ultrasound Market, By Connectivity
Connectivity classification distinguishes the physical and wireless methods used to transfer images and connect handheld scanners to viewing devices and clinical networks. Wired systems connect through a physical interface, offering a straightforward connection structure and reducing reliance on wireless network availability. Wireless systems transmit images to compatible smartphones, tablets, or dedicated receivers, supporting movement between examination locations and reducing cable-related constraints. Buyers evaluate connection stability, latency, encryption, device compatibility, battery consumption, and network security. Wireless connectivity holds the leading commercial position in modern mobile workflows because it supports flexible bedside and remote use. Wired configurations retain relevance where controlled connectivity, compatibility, or specific operational requirements determine purchasing decisions. Growth is strongest in secure wireless platforms that support enterprise authentication, image transfer, and integration with hospital information systems.
United States Handheld Ultrasound Market, By Clinical Application
Clinical application segments demand according to the medical purpose of imaging. Emergency medicine and critical care use handheld systems for focused assessments during triage, resuscitation, and bedside monitoring. Cardiology supports focused cardiac evaluation, while obstetrics and gynecology address selected pregnancy and reproductive health examinations. Musculoskeletal imaging supports evaluation of joints, tendons, and soft tissues. Vascular imaging assists blood-flow assessment and procedural guidance. Abdominal, urology, and pulmonary applications extend use across internal organs, urinary conditions, and respiratory assessment. Other applications include dermatology, pain management, and selected veterinary or specialty workflows where included in the market scope. Emergency and critical care represent a major established application because clinicians value immediate bedside information. Cardiology and musculoskeletal imaging also sustain institutional purchasing. Primary care, pulmonary assessment, and application-specific AI tools represent attractive expansion areas as device usability and clinical training improve.
United States Handheld Ultrasound Market, By End User
End-user classification reflects the facility or organization purchasing and operating handheld ultrasound equipment. Hospitals remain central buyers because they deploy devices across emergency departments, intensive care, inpatient wards, and specialty services. Specialty clinics and primary care clinics use compact scanners to support focused consultations and improve access to imaging. Ambulatory surgical centers require portable imaging for selected preoperative, procedural, and postoperative workflows. Diagnostic imaging centers use handheld systems for targeted applications alongside conventional equipment. Emergency medical services prioritize portability and rapid deployment, while home healthcare providers use devices in appropriately supervised care pathways. Academic and research institutions purchase systems for education, simulation, and clinical research. Veterinary care providers form a distinct commercial segment with specialized product and workflow requirements. Hospitals retain the largest institutional purchasing base, while primary care, ambulatory, and mobile healthcare settings offer attractive expansion opportunities as training and reimbursement frameworks mature.
United States Handheld Ultrasound Market, By Software & Workflow Capability
Software and workflow capability separates basic image acquisition from advanced clinical and enterprise functionality. Basic imaging software provides scanning controls, presets, image capture, and fundamental measurements. AI-assisted imaging and measurement tools support selected automated calculations, anatomy identification, and examination guidance. Image management and reporting software enables storage, annotation, review, and documentation. Tele-ultrasound and remote collaboration tools support image sharing, supervision, and consultation across locations. Enterprise integration and workflow platforms connect devices with hospital information systems, electronic health records, and imaging archives. Buyers increasingly assess software as part of the total device investment because clinical deployment requires secure documentation, user management, and consistent image handling. Basic imaging remains a core requirement across all device classes. AI-assisted functions and enterprise integration represent the fastest-developing commercial categories as institutions seek standardization, improved workflow efficiency, and scalable multi-site deployment.
| Market Snapshot | Details |
| Market Name | United States Handheld Ultrasound Market |
| Base Year | 2025 |
| Historical Period | 2021–2024 |
| Forecast Period | 2026–2035 |
| Market Segmentation | By Device Configuration, By Imaging Technology, By Transducer Type, By Connectivity, By Clinical Application, By End User, By Software & Workflow Capability, By Region |
| Regions Covered | United States (North America, Europe, Asia Pacific, Latin America, Middle East & Africa as specified in the segmentation) |
| Market Analysis in | Revenue (USD Million) |
| Market Size (2025) | USD 397.29 Million |
| Forecast Value (2035) | Approximately USD 1.27 Billion |
| CAGR (2026–2035) | 12.3% |
| Company Profiles Covered | 15+ Leading Global Companies |
| Report Coverage | Market Size, Market Share, Growth Analysis, Market Forecast, Value Chain Analysis, Pricing Analysis, Procurement Intelligence, Competitive Landscape, Technology Trends, AI-Assisted Imaging Analysis, Point-of-Care Diagnostics & Regional Insights |
| Report Pages | 250+ Pages |
| Report Format | PDF, Excel Data Pack & PPT |
| Customization | Up to 25% Free Customization |
| Delivery | 24–48 Hours |
| License Options | Single User, Multi User & Enterprise License |
| Analyst Support | One-Year Post-Sales Analyst Support |
| Analyst Contact | [email protected] |
MARKET ANALYSIS REPORT
Strategic Market Snapshot
The commercial outlook is shaped by the transition from centralized imaging access toward distributed point-of-care assessment. Handheld ultrasound does not replace comprehensive diagnostic imaging systems; it expands the locations and clinical moments in which focused ultrasound examinations take place. This distinction is important for procurement teams evaluating clinical suitability, equipment utilization, and capital allocation.
Hardware differentiation increasingly depends on transducer design, imaging performance, battery life, durability, and compatibility with mobile devices. Software differentiation centers on automated measurements, clinical guidance, image management, and secure integration. Institutional buyers also assess training, credentialing, service availability, and the ability to manage devices across departments.
The strongest commercial positioning belongs to vendors that combine dependable imaging with application-specific workflows and predictable ownership costs. Subscription-based software, enterprise licensing, accessories, education, and support create additional revenue opportunities. Over the forecast period, market competitiveness will depend on clinical validation, regulatory compliance, interoperability, and the ability to scale deployments beyond individual clinicians.
Value Chain, Cost Structure & Procurement Intelligence
The value chain spans transducer and semiconductor development, electronics manufacturing, device assembly, imaging software, regulatory clearance, distribution, clinical training, and post-sale support. Hardware costs reflect probe architecture, semiconductor components, display configuration, battery systems, and manufacturing quality. Vendor pricing also incorporates software access, AI functionality, warranties, accessories, service contracts, and enterprise integration. Buyers therefore compare total cost of ownership rather than initial device price alone.
Procurement cycles differ by customer type. Hospitals and integrated delivery networks typically require clinical evaluation, cybersecurity review, capital approval, vendor qualification, and integration assessment. Smaller clinics and individual practitioners prioritize affordability, ease of use, and rapid deployment. Implementation complexity increases when systems require mobile-device management, image archiving, user authentication, or electronic record integration. Vendors that provide standardized onboarding, training, technical support, and transparent licensing reduce deployment friction. Operating efficiency improves when devices are shared across clinical teams, properly maintained, and integrated into documented examination pathways.
Market Restraints & Regulatory Challenges
Clinical performance limitations remain a restraint where handheld devices cannot provide the depth, image quality, or examination breadth required for comprehensive diagnostic studies. Operator dependency and inconsistent training also affect examination quality, making credentialing and clinical governance essential. Healthcare organizations must establish protocols that distinguish focused point-of-care examinations from comprehensive imaging and ensure appropriate referral when findings require specialist assessment.
Regulatory compliance adds complexity across device hardware, software, AI-enabled functions, and cybersecurity. Manufacturers must address applicable FDA requirements in the United States and relevant conformity frameworks in international markets. Data privacy, secure image transmission, mobile-device management, and interoperability with hospital systems influence purchasing approval. Deployment resistance also arises when clinicians lack confidence, workflows are poorly defined, or reimbursement arrangements do not adequately support the service. Enterprise risk management therefore requires clinical validation, training, data protection, and clear responsibility for image interpretation.
Market Opportunities & Outlook 2026–2035
The next phase of industry expansion is linked to broader clinical deployment and software-led differentiation. Enterprise AI expansion will support automated measurements, image optimization, anatomy recognition, and guided scanning, provided that functions remain clinically validated and appropriately regulated. Workflow automation will reduce repetitive documentation and simplify image transfer, review, and reporting. These capabilities create opportunities for vendors to develop recurring software revenue and differentiated enterprise packages.
Vertical specialization will strengthen product positioning across cardiology, emergency medicine, obstetrics, musculoskeletal care, vascular access, and primary care. Application-specific presets, probes, and AI tools will help vendors address distinct clinical workflows rather than relying on generic device propositions. Multilingual interfaces and training resources will support international deployment and clinician education across diverse healthcare systems. Customer engagement transformation will also influence commercial models through remote demonstrations, digital onboarding, subscription management, and connected service support. Companies that combine clinical evidence, scalable software, and accessible training will be better positioned to convert pilot deployments into institutional purchasing programs.
Technology, Innovation & Derivative Trends
Innovation is shifting from miniaturization alone toward improved imaging performance and software-enabled clinical assistance. Generative AI is relevant to documentation, structured reporting, training content, and clinical workflow support, although diagnostic outputs require appropriate validation and oversight. Multimodal interaction combining ultrasound images, measurements, patient information, and clinical notes can support more complete examination records. Retrieval-augmented generation offers a pathway for controlled access to approved clinical protocols and device documentation, subject to governance and data integrity controls.
Conversational analytics can simplify access to examination records and operational insights, while API interoperability enables secure exchange with electronic health records, imaging archives, and hospital information systems. Enterprise orchestration supports device management, user access, software updates, and standardized workflows across multiple facilities. Further innovation will center on edge processing, wireless performance, automated image quality assessment, AI-assisted acquisition, and integration with tele-ultrasound services. Commercial differentiation will depend on demonstrating clinical utility while maintaining security, transparency, and regulatory compliance.
Competitive Landscape Overview
Competition is defined by imaging performance, transducer architecture, software capabilities, clinical validation, distribution reach, and total cost of ownership. Established medical imaging companies leverage broad healthcare relationships, service infrastructure, and integration expertise, while specialized handheld manufacturers compete through compact hardware, wireless workflows, and focused software innovation. Pricing structures range from upfront hardware purchases to bundled packages incorporating software subscriptions, AI tools, accessories, and support.
Deployment specialization is an important differentiator. Some vendors emphasize whole-body scanning through single-probe semiconductor technology, while others provide dual-probe or multi-transducer configurations for specialty coverage. Enterprise integration, cybersecurity, training, and technical support influence large-scale purchasing decisions. Partnerships with hospitals, medical schools, distributors, and digital health providers strengthen market access. Competitive advantage increasingly depends on a complete clinical workflow proposition rather than device portability alone.
Key Players in the United States Handheld Ultrasound Market
- GE HealthCare Technologies Inc.
- Butterfly Network, Inc.
- Clarius Mobile Health Corp.
- Koninklijke Philips N.V.
- FUJIFILM Holdings Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens Healthineers AG
- Exo Imaging, Inc.
- Canon Medical Systems Corporation
- Konica Minolta, Inc.
- EagleView Ultrasound
- Healcerion Co., Ltd.
Recent Developments — United States Handheld Ultrasound Market (2025–2026)
Recent commercial activity emphasizes AI-enabled applications, regulatory clearances, and specialty-specific handheld imaging workflows. These developments demonstrate how manufacturers are extending device functionality through software and application packages, creating additional differentiation beyond compact hardware and wireless connectivity.
- May 2025 — GE HealthCare received FDA 510(k) clearance for Vscan Air, supporting continued commercialization of its handheld ultrasound platform.
- April 2025 — Clarius announced FDA clearance for Prostate AI, adding automated prostate measurement functionality to its handheld ultrasound ecosystem.
- May 2025 — Clarius announced FDA clearance for Median Nerve AI, expanding application-specific ultrasound assistance for assessment of carpal tunnel syndrome.
- October 2025 — Butterfly Network launched Butterfly iQ3 Vet in the United States and Canada, extending its handheld ultrasound portfolio into veterinary care.
- March 2026 — Butterfly Network received FDA clearance for an AI-powered gestational-age estimation tool, expanding software-enabled prenatal ultrasound applications.
- May 2026 — Clarius announced CE-marked AI models for handheld ultrasound, supporting expanded commercial availability across European markets.
- June 2026 — Clarius announced FDA clearance for Ejection Fraction AI, extending automated cardiac assessment capabilities for handheld ultrasound users.
- November 2026 — Clarius released App 13.1 with an integrated portfolio of AI models, expanding automated measurements and clinical workflow support.
Methodology & Data Credibility
The market assessment combines bottom-up modeling of handheld ultrasound device revenues with top-down analysis of medical imaging expenditure, point-of-care ultrasound deployment, and manufacturer activity. Market estimates are triangulated using company disclosures, product portfolios, regulatory records, distributor information, procurement indicators, and relevant healthcare technology research. Executive interviews with medical imaging specialists, procurement professionals, clinical users, distributors, and industry participants provide qualitative context on purchasing priorities and deployment barriers. Demand-side validation examines clinical utilization, facility adoption, device replacement, and software requirements, while supply-side validation assesses manufacturer revenue exposure, product availability, pricing structures, and channel reach. Cross-region verification accounts for differences in healthcare infrastructure, reimbursement, regulation, and purchasing practices. Forecast assumptions reflect device commercialization, application expansion, software monetization, and competitive conditions.
Who Should Read This Report
This report is designed for medical device manufacturers, ultrasound equipment suppliers, healthcare technology investors, hospital procurement executives, and distributors evaluating the handheld imaging category. Product development teams can use the analysis to assess transducer configurations, imaging capabilities, software features, and specialty-specific opportunities. Hospital administrators and clinical department leaders can benchmark deployment models, procurement priorities, and workflow integration requirements. Private equity firms, venture capital investors, and corporate strategy teams can assess competitive positioning, market entry conditions, and potential acquisition opportunities. The report also supports healthcare consultants, contract manufacturers, component suppliers, and digital health companies seeking to understand the commercial implications of AI-enabled imaging, connected devices, and decentralized diagnostic services.
What This Report Delivers
The report provides a structured assessment of market size, historical performance, forecast outlook, competitive positioning, and commercial opportunities across the handheld ultrasound industry. It evaluates demand by device configuration, imaging technology, transducer type, connectivity, clinical application, end user, software and workflow capability, and geographic region. The analysis covers purchasing behavior, device economics, regulatory requirements, technology development, and clinical deployment considerations. Company assessments identify relevant product portfolios, strategic initiatives, and differentiation factors. Regional analysis highlights variations in healthcare infrastructure, procurement practices, and adoption conditions. The report also examines AI-enabled functionality, enterprise integration, service models, and emerging clinical applications, helping decision-makers evaluate investment priorities, product strategies, market entry options, and long-term commercial positioning.
United States Handheld Ultrasound Market Report Segmentation
By Device Configuration
- Smartphone-Connected Handheld Systems
- Tablet-Connected Handheld Systems
- Handheld Systems with Integrated Display
By Imaging Technology
- 2D Imaging
- 3D/4D Imaging
- Doppler Imaging
By Transducer Type
- Linear Array
- Phased Array
- Curvilinear Array
- Endocavity
- Multi-Array
By Connectivity
- Wired
- Wireless
By Clinical Application
- Emergency Medicine & Critical Care
- Cardiology
- Obstetrics & Gynecology
- Musculoskeletal Imaging
- Vascular Imaging
- Abdominal Imaging
- Urology
- Pulmonary Imaging
- Other Applications
By End User
- Hospitals
- Specialty Clinics
- Primary Care Clinics
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Emergency Medical Services
- Home Healthcare Providers
- Academic & Research Institutions
- Veterinary Care Providers
By Software & Workflow Capability
- Basic Imaging Software
- AI-Assisted Imaging & Measurement
- Image Management & Reporting
- Tele-Ultrasound & Remote Collaboration
- Enterprise Integration & Workflow Platforms
| ATTRIBUTES | DETAILS |
|---|---|
|
Market Size (Current)
Current market valuation
|
USD ($) 397.29 USD Million in 2025 |
|
Market Size (Forecast)
Projected market valuation
|
USD ($) 1.27 USD Billion in 2035 |
|
Growth Rate
Compound Annual Growth Rate
|
CAGR of 12.3% from 2026 to 2035 |
|
Forecast Period
Analysis timeline
|
2026 - 2035 |
|
Base Year
Reference year for analysis
|
2025 |
|
Historical Data Available
Past market data availability
|
2022 - 2024 |
|
Regional Scope
Geographical coverage
|
Global |
|
Segments Covered
Market segments analyzed
|
By Device Configuration
By Imaging Technology
By Transducer Type
By Connectivity
By Clinical Application
By End User
By Software & Workflow Capability
|
Key Market Players
Leading companies covered in this report
- GE HealthCare Technologies Inc.
- Butterfly Network
- Inc.
- Clarius Mobile Health Corp.
- Koninklijke Philips N.V.
- FUJIFILM Holdings Corporation
- Shenzhen Mindray Bio-Medical Electronics Co.
- Ltd.
- Siemens Healthineers AG
- Exo Imaging
- Inc.
- Canon Medical Systems Corporation
- Konica Minolta
- Inc.
- EagleView Ultrasound
- Healcerion Co.
- Ltd.
Frequently Asked Questions
Common questions about this market report.
About the Author
Mrudula Shah
Senior Research Analyst
As a Senior Consultant in Market Research, I help businesses make informed decisions through data analysis. I specialize in secondary and primary research, market estimation. My expertise ensures reliable and actionable market insights.
I hold an M.Sc. in Applied Microbiology from VIT Vellore and a B.Sc. in Microbiology from Fergusson College, Pune. My scientific background enhances my analytical skills in market research.
Passionate about driving business growth, I aim to provide high-quality data and insights.
Detailed Table of Contents
US Handheld Ultrasound Market Segmentation
The global US Handheld Ultrasound Market is segmented based on the following categories, providing a detailed breakdown for comprehensive analysis:
| Segment Category | Segment Values |
|---|---|
| By Device Configuration |
|
| By Imaging Technology |
|
| By Transducer Type |
|
| By Connectivity |
|
| By Clinical Application |
|
| By End User |
|
| By Software & Workflow Capability |
|
Research Methodology
Our research methodology is carefully designed to deliver the clients with the most accurate, relevant, and actionable market insights to enable clear decision-making and leveraging of opportunities in the markets. We believe consistency, depth in analysis, and a tailored approach in each report are what help set us apart in the industry. The research methodology is based on an integrating research process consisting of in-depth data collection, a complex analysis, and a stringent validation system.
Data Collection
Data collection forms the basis of our study and gathers diverse authentic data to build the basis for deeper study in terms of market trends, competitive landscape, and growth prospects for US Handheld Ultrasound Market. Data collection takes place through two channels of main activities as follows:
Primary Data Collection
Primary data collection allows collecting real-time and firsthand information from market participants. This is an engagement process conducted by our team with other industry stakeholders, where a much deeper insight than any published data is pursued. This process includes:
- Direct Interviews – We interview the key decision-makers such as CEOs, product managers, innovation heads, and marketing directors to gather both qualitative and quantitative information. The questionnaire covers emerging trends, customer preferences, regulatory impact, and competitors’ strategies.
- Demand and Supply-Side Inputs – Interviews and surveys with supply and demand-side stakeholders provide a balanced view of prevailing market conditions, including feedback from manufacturers, distributors, suppliers, and end-users.
- Expert Opinions – Consultations with industry experts and domain specialists provide insights into future market direction, risks, and opportunities.
- Focus Groups and Online Surveys – Focus groups and surveys are used to understand consumer preferences and adoption probability of new products or services.
Primary research forms the core of our data validation process by offering direct insights into the market, addressing limitations in secondary data, and allowing for an adaptable research process.
Secondary Data Collection
Secondary research serves as a robust foundation for understanding market context, historical data, and larger trends. It involves systematic gathering of existing information from verified sources.
- Industry Reports and Publications – Market reports, white papers, and case studies from credible sources provide a broad view of the market landscape and key players.
- Government and Public Records – Data from government agencies and regulatory bodies helps analyze economic factors and policy impacts.
- News and Media Outlets – Monitoring news articles, press releases, and media reports keeps us updated on market developments and M&A activity.
- Proprietary and Paid Databases – Databases such as Bloomberg, Factiva, D&B Hoovers, and Thomson Reuters provide validated and cross-referenced data.
- Financial Reports and SEC Filings – Financial statements, annual reports, and investor presentations provide insights into revenue structures and profitability.
This combination of primary and secondary data sources enables us to provide a comprehensive view of the US Handheld Ultrasound Market, supported by authenticated information across multiple sources.
Data Analysis Techniques
With the data collected, we initiate a rigorous analysis phase. We analyze market dynamics, growth patterns, and future performance using analytical models and statistical tools.
Top-Down and Bottom-Up Market Sizing Approaches
- Top-Down Approach – Starts with global market size and distributes it across segments using macro-level trends and established proportions.
- Bottom-Up Approach – Aggregates company-level and country-level revenue data to build regional and global market estimates.
These two approaches are cross-validated to remove inconsistencies and ensure accurate market estimation.
Forecasting Models and Market Dynamics Analysis
- Time-Series Analysis – Models historical trends, seasonality, and demand cycles.
- Econometric and Judgmental Forecasting – Combines economic models with expert-driven adjustments.
- Delphi Method – Uses iterative expert input to generate balanced market forecasts.
Data Triangulation and Validation
- Multi-source cross-verification of all data points
- Use of quantitative and qualitative validation techniques
- Sample validation through expert and stakeholder feedback
Market Analysis and Sizing Estimation
- Detailed segmentation analysis
- Competitive landscape evaluation
- Revenue modeling using TAM, SAM, and SOM frameworks
Quality Assurance and Final Review
- Data accuracy and consistency checks
- Content, language, and structure review
- Client-specific customization and refinement
Continuous Improvement in Methodology
We continuously refine our research methodologies based on evolving market conditions, client feedback, and technological advancements. This ensures our research remains accurate, relevant, and aligned with industry standards.